Publication in Nature's Scientific Reports Reinforces Spiderwort Biotechnologies' Cellulose-Based Platform with New Findings on Neural Repair and Motor Recovery
Peer-reviewed study highlights collaboration between University of Ottawa and Spiderwort Biotechnologies Inc. OTTAWA, CANADA — December 10, 2025 — A new peer-reviewed study published in Scientific Reports, part of the prestigious Nature Portfolio, demonstrates plant-derived scaffolds can promote neural tissue […]
Spiderwort Biotechnologies Inc. Receives Health Canada Investigational Testing Authorization for Next-Generation Dermal Filler
CelluJuve® represents the next-generation in medical aesthetics leveraging Spiderwort Biotechnologies regenerative cellulose-based technology platform OTTAWA, CANADA — June 10, 2025 — Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced it has received Investigational Testing […]
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, CANADA — April 29, 2025 — Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced the completion of ISO 10993 biocompatibility […]
Spiderwort Biotechnologies Inc. Announces State-of-the-Art ISO 5 Cleanroom Facility
New facility built exclusively by Spiderwort Biotechnologies Inc. will advance its mission to revolutionize regenerative medicine treatments OTTAWA, CANADA — March 31, 2025 — Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced its state-of-the-art […]
Spiderwort Selected to Join Elite CELS Valley Ready Program
Admission to Prestigious Program to Bolster Biotechnology Firm’s Global Reach in Life Sciences Ottawa, Canada — November, 22, 2023 — Spiderwort Inc., the biotechnology company innovating in cellulose-based tissue engineering, today announced its acceptance to the prestigious Canadian Entrepreneur in […]
Spiderwort Embarks on November European Tour
Forging Global Partnerships in Regenerative Medicine Ottawa, Canada — October, 27, 2023 — Spiderwort Inc, the biotech company leading in regenerative medicine, will embark on a regional European tour this upcoming November with a focus on building partnerships with researchers, […]
Spiderwort Accepted to Tech Accelerator, MaRS Health Science Portfolio
This important milestone follows Spiderwort’s graduation to Invest Ottawa’s “ScaleUp” venture development program Ottawa — June 6, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been accepted to the prestigious […]
Spiderwort Wins Prestigious Judge's Choice Award at Industry-Leading Octane Medical Aesthetics Tech Forum
This award follow’s Spiderwort’s inaugural presentation to the medical aesthetics industry in the U.S. market. Ottawa — February 7, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been selected as […]
Whiteboard Foods Withdraws from XPRIZE's Feed The Next Billion
Ottawa — February 2, 2023 —After careful consideration, Whiteboard Foods Inc., a subsidiary of Spiderwort Inc, has withdrawn from XPRIZE’s Feed The Next Billion competition, effective Jan 30, 2023. Whiteboard Foods was honoured to be amongst the top 26 semi-finalist […]
Spiderwort secures $13.2M USD in Series A Financing to Accelerate Clinical Trials of Revolutionary Biomaterials
Spiderwort to use funding to advance biotechnology innovations to treat acute spinal cord injuries. OTTAWA – July 12, 2022 – Spiderwort Inc., the biotech company innovating in cellulose-based tissue scaffolding to treat acute spinal cord injuries, today announced the successful […]
Please contact us for press kit or media inquiries.
Contact Us